fls.txt
The Management’s Discussion and Analysis of Financial Condition and Results of Operations ("MD&A") in this Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that involve risks and uncertainties, which are discussed in the "Cautionary Note Regarding Forward-Looking Statements" section in Part I of this Quarterly Report on Form 10-Q.


item1.txt
The restructuring charge of $90.1 million recorded for the fiscal year ended January 3, 2016 primarily consists of severance costs, lease termination costs and impairment of property, plant and equipment.
The intangible assets attributable to the NAND business acquired as part of a previous acquisition were $10.9 million.
On March 18, 2019, the Company repaid $25.0 million of the outstanding Term Loan B principal in addition to the scheduled quarterly principal payment of $1.3 million.
When the forecasted transaction occurs, the Company reclassifies the related gain or loss on the cash flow hedge to revenue or costs, depending on the risk hedged.
During the fourth quarter of fiscal 2017, we determined that our investment in Enovix Corporation, which is accounted for as an equity method investment, was other-than temporarily impaired as Enovix did not achieve key planned product development milestones.
Fiscal years 2019 and 2018 each contain(ed) 52 weeks.
Additionally, Cypress will provide certain transition and back-end manufacturing services to SkyHigh.
The first quarter of fiscal 2019 ended on March 31, 2019 and the first quarter of fiscal 2018 ended on April 1, 2018.
During the fourth quarter of fiscal 2017, we determined that our investment in Enovix Corporation, which is accounted for as an equity method investment, was other-than temporarily impaired as Enovix did not achieve key planned product development milestones.
The following table represents the assets and liabilities held by Deca as of March 31, 2019 and December 30, 2018.
The below table presents the changes in carrying value of the equity method investment related to Deca.
On April 1, 2019, the Company closed the transfer of its NAND business to a newly-formed joint venture between the Company and SK hynix system ic ("SKHS").
The lease termination cost was approximately $19.0 million.
Based on an analysis carried out in the fourth quarter of fiscal 2018, the Company recorded an impairment charge of $76.6 million which related to the goodwill and intangible assets allocated to the NAND business and classified as held-for-sale.
Deca continues to be in the process of developing and testing a fan-out wafer level packaging technology.
December 31, 2018.
The Company's leases have remaining lease terms of 1 year to 8 years, some of which include options to extend the leases for up to 5 years, and some of which include options to terminate the leases within the lease terms.
The intangible assets attributable to the NAND business acquired as part of a previous acquisition were $10.9 million.
As of March 31, 2019, the Company was in compliance with all of the financial covenants under all of its debt facilities.


item2.txt
Our Revolving Credit Facility has a capacity of $540 million which was undrawn as of March 31, 2019.
Our Revolving Credit Facility has a capacity of $540 million which was undrawn as of March 31, 2019.
•property and equipment expenditures of $10.5 million relating to purchases of certain manufacturing facility equipment;
Note 1 of the Notes to Condensed Consolidated Financial Statements under Part I, Item 1 describes the significant accounting policies and methods used in the preparation of the consolidated financial statements.
As of March 31, 2019, our cash, cash equivalents and short-term investment balance was $285.1 million as compared to $285.7 million as of December 30, 2018.


item3.txt
•sales of our products to Japanese distributors are denominated in U.S. dollars, Japanese yen and Euros;


item4.txt
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


part2.txt
As of March 31, 2019, the carrying value of our investment in Deca was $61.6 million.
The information required by this item is included in Note 11 of the Notes to Condensed Consolidated Financial Statements in Part I Item 1, of this Quarterly Report on Form 10-Q and is incorporated herein by reference.


